• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Polypharmacy associated with medical tourism: a critique on drug therapy.

作者信息

Al Khaja Khalid A J, Sequeira Reginald P, Damanhori Awatif H H

机构信息

Department of Pharmacology & Therapeutics, Arabian Gulf University, PO Box 22979, Manama, Kingdom of Bahrain.

出版信息

Int J Clin Pharm. 2011 Feb;33(1):61-5. doi: 10.1007/s11096-010-9477-7. Epub 2011 Jan 13.

DOI:10.1007/s11096-010-9477-7
PMID:21365396
Abstract
摘要

相似文献

1
Polypharmacy associated with medical tourism: a critique on drug therapy.与医疗旅游相关的多重用药：对药物治疗的批判
Int J Clin Pharm. 2011 Feb;33(1):61-5. doi: 10.1007/s11096-010-9477-7. Epub 2011 Jan 13.
2
Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).改善老年患者药物治疗的规则：第1部分（规则1 - 5）。
South Med J. 2015 Feb;108(2):97-104. doi: 10.14423/SMJ.0000000000000243.
3
Commentary on "rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5)".
South Med J. 2015 Feb;108(2):105-6. doi: 10.14423/SMJ.0000000000000244.
4
Diagnosis and control of polypharmacy in the elderly.老年人多重用药的诊断与控制
Rev Saude Publica. 2007 Dec;41(6):1049-53. doi: 10.1590/s0034-89102006005000050. Epub 2007 Dec 4.
5
Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.老年人的精神药理学治疗：避免药物相互作用和多种药物治疗。
Dtsch Arztebl Int. 2019 Jul 22;116(29-30):508-518. doi: 10.3238/arztebl.2019.0508.
6
Polypharmacy: the cure becomes the disease.多种药物并用：治愈之法反成致病之源。
J Gen Intern Med. 1993 May;8(5):278-83. doi: 10.1007/BF02600099.
7
Clinical decision support systems: great promises for better management of patients' drug therapy.临床决策支持系统：为更好地管理患者药物治疗带来巨大前景。
Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):993-5. doi: 10.1517/17425255.2016.1171317. Epub 2016 Apr 11.
8
Polypharmacy, adverse drug reactions, and geriatric syndromes.多种药物治疗、药物不良反应和老年综合征。
Clin Geriatr Med. 2012 May;28(2):173-86. doi: 10.1016/j.cger.2012.01.002.
9
Prescribed drugs: a major cause of ill health.
Aust Health Rev. 1999;22(3):210-2.
10
Pharmacotherapy consultation on polypharmacy patients in ambulatory care.
Ann Pharmacother. 2001 Jul-Aug;35(7-8):835-40. doi: 10.1345/aph.10259.

引用本文的文献

1
Bibliometrix analysis of medical tourism.医学旅游的文献计量分析。
Health Serv Manage Res. 2022 Aug;35(3):172-188. doi: 10.1177/09514848211011738. Epub 2021 May 7.
2
Overview of this issue: pharmacovigilance, what is new?本期概述：药物警戒，有哪些新进展？
Int J Clin Pharm. 2018 Aug;40(4):737-739. doi: 10.1007/s11096-018-0719-4.
3
A systematic review of publications studies on medical tourism.一项关于医疗旅游出版物研究的系统综述。

本文引用的文献

1
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.2007年1月至2008年5月期间罗格列酮和吡格列酮的使用与五项风险警示事件相关。
J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31. doi: 10.18553/jmcp.2008.14.6.523.
2
Medical tourism: globalization of the healthcare marketplace.医疗旅游：医疗保健市场的全球化。
MedGenMed. 2007 Nov 13;9(4):33.
3
Treatment of diabetic neuropathy and neuropathic pain: how far have we come?糖尿病性神经病变和神经性疼痛的治疗：我们取得了多大进展？
J Educ Health Promot. 2013 Sep 30;2:51. doi: 10.4103/2277-9531.119037. eCollection 2013.
4
Medical Tourism Abroad: A new challenge to Oman's health system - Al Dakhilya region experience.国外医疗旅游：阿曼医疗系统面临的新挑战——达希利亚地区的经验
Sultan Qaboos Univ Med J. 2011 Nov;11(4):477-84. Epub 2011 Oct 25.
Diabetes Care. 2008 Feb;31 Suppl 2:S255-61. doi: 10.2337/dc08-s263.
4
New perspectives on the management of diabetic peripheral neuropathic pain.糖尿病性周围神经病理性疼痛管理的新视角
Diab Vasc Dis Res. 2006 Sep;3(2):108-19. doi: 10.3132/dvdr.2006.013.
5
Alpha-glucosidase inhibitors for type 2 diabetes mellitus.用于2型糖尿病的α-葡萄糖苷酶抑制剂
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD003639. doi: 10.1002/14651858.CD003639.pub2.
6
Safety of statins: focus on clinical pharmacokinetics and drug interactions.他汀类药物的安全性：关注临床药代动力学和药物相互作用。
Circulation. 2004 Jun 15;109(23 Suppl 1):III50-7. doi: 10.1161/01.CIR.0000131519.15067.1f.
7
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.依折麦布与辛伐他汀联合使用相较于阿托伐他汀在高胆固醇血症成人患者中的疗效与安全性。
Am J Cardiol. 2004 Jun 15;93(12):1487-94. doi: 10.1016/j.amjcard.2004.02.060.
8
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.噻唑烷二酮类药物的使用、液体潴留与充血性心力衰竭：美国心脏协会和美国糖尿病协会的共识声明
Diabetes Care. 2004 Jan;27(1):256-63. doi: 10.2337/diacare.27.1.256.
9
Dyslipidemia management in adults with diabetes.糖尿病成人患者的血脂异常管理
Diabetes Care. 2004 Jan;27 Suppl 1:S68-71. doi: 10.2337/diacare.27.2007.s68.
10
Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.2型糖尿病患者使用口服抗糖尿病药物时发生低血糖的风险。
Exp Clin Endocrinol Diabetes. 2003 Oct;111(7):405-14. doi: 10.1055/s-2003-44287.